NSEOptions to purchase securities1d ago · 24 Sept 2026, 04:49 pm

Options to purchase securities

Thyrocare Technologies Limited · THYROCARE

✦ AI Summaryoptions

Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme, where 1,92,000 options were granted to eligible employees at an exercise price of Rs. 10/- per Option.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Thyrocare Technologies Limited has informed the Exchange about Grant of Options under Thyrocare Employee Stock Option Scheme.

Attachments (1)

📄

THYROCARE_24092026164919_SE_ESOS_Grant.pdf

pdf

Download →
View document text
September 24, 2026 The National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers B(SaYnMdeBrOa LK:u TrlHaY CRoOmCpAleRxE, ) D(SaClaRlI SPt rCeOeDt, E 539871) B andra (E), Mumbai - 400051 Mumbai- 400001 Sub: Grant of Employee Stock Options (“Options”) under Thyrocare Employee Stock Option Scheme (“Scheme”) Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of Listing Regulations, we wish to inform that the Members of Nomination and Remuneration Committee (“NRC”) of the Board of Directors of Thyrocare Technologies Limited (“Company”), have approved and granted 1,92,000 number of Options to the eligible employees of the Company at an exercise price of Rs. 10/- per Option under the Thyrocare Employee Stock Option Scheme (“Scheme”) today, Thursday, September 24, 2026 at 03:49 P.M. The Options shall vest subject to the fulfillment of the applicable vesting conditions. Further the details required to be disclosed pursuant toA Rnengeuxluatrieo-n1 30 of the Listing Regulations, read with the SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, are enclosed as . The aforesaid disclosure is also being made available on the website of the Company at www.thyrocare.com. This is for your information and records. Thyrocare Technologies Limited, Y ours Faithfully, Brijesh Kumar Company Secretary and Compliance Officer Annexure-1 D isclosure pursuant to Regulation 30 of the Listing Regulations, read with the SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Grant of Employee Stock Options (“Options”) under Thyrocare Employee Stock Option Scheme (“Scheme”) S. No. Particulars Details 1. Brief details of options granted; Grant of 1,92,000 (One Lakh Ninety- Two Thousand Only) Options to the eligible employees as determined by the NRC. 2. Whether the scheme is in terms of SEBI Yes (SBEB) Regulations, 2021 (if applicable); 3. Total number of shares covered by these 1,92,000 equity shares since each options; Option is convertible into one (1) equity share of the Company having a face value of Rs. 10/- each subject to the adjustments, if any, due to any corporate actions in the Company as mentioned in the Scheme. 4. Pricing formula/Exercise Price; The exercise price is Rs. 10/- per Option as per the Scheme and as approved by the NRC. 5. Options Vested (Vesting Schedule) Subject to the fulfillment of conditions mentioned in the Scheme and grant letter, one-third of the Options granted shall vest at the end of each year over three (3) years, provided the employee remains in continuous employment on the respective vesting dates or as may be determined by the NRC from time to time. 6. Time within which option may be exercised Employees may exercise their (Exercise Period); Options within (7) seven years from the date of vesting, or any other period approved by the NRC or the Board as per the Scheme. 7. Brief details of significant terms; As per the Scheme 8. Options exercised; Not Applicable, as this intimation is 9. Money realized by exercise of options; pertaining to grant of Options under 10. The total number of shares arising as a the Scheme. result of exercise of option; 11. Options lapsed; 12. Variation of terms of options; 13. Subsequent changes or cancellation or exercise of such options; 14. Diluted earnings per share pursuant to issue of equity shares on exercise of options;